Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ancora Sends Letter to U.S. Steel Stockholders Regarding its Slate’s Win-Win Solution to Maximize Value
-
UGREEN Showcases the New AI-Powered NASync iDX Series at NAB Show 2025, Transforming Data Management for Content Creators
-
Mercedes-Benz USA Reports Year-Over-Year Passenger Car Sales Growth for Q1 2025
-
Ascent Industries Co. Announces Successful Completion of Sale of Bristol Metals, LLC
-
NextPoint Therapeutics to Highlight Antibody-Drug Conjugate (ADC) and T Cell Engager (TCE) Preclinical Findings Targeting Novel B7-H7 Pathway at AACR Annual Meeting
-
S5 Equity Acquires Iconic Southern California Retailer, Howard's Appliances
-
Amneal Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson’s Disease
-
Franklin Templeton Announces Distribution Rates for Putnam Closed-End Funds
-
Leidos unveils newest unmanned undersea vessel
-
Anduril and Ultra Maritime Announce Exclusive Partnership on Groundbreaking Autonomous Ocean Sensing Capability
-
Altus Capital Partners Together With Centerfield Capital and ALM Management Acquire ALM Positioners, Inc.
-
Alight Marks Onboarding of 200th Pension Risk Transfer Transaction
-
Scienaptic AI and Tristate Collaborative Partner to Bring AI-Driven Lending to Credit Unions
-
Apnimed Provides Clinical Updates for Multiple Product Candidates
-
Cognyte Announces Agenda for Virtual Analyst and Investor Day on April 8
-
JPEG XS Technology Integrated by Cobalt Digital With intoPIX TicoXS FIP Codec, Supporting High Profile and New TDC Profile
-
Picton Mahoney Asset Management Named One of the 2025 Best Workplaces™ in Canada for the 6th Consecutive Year
-
LANDSEA HOMES CLOSES ON 78 HOMESITES IN THE MOONLIGHT MASTER- PLANNED COMMUNITY IN MARICOPA, ARIZONA
-
Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer
-
Similarweb Expands Digital Visibility to AI Chatbots Like ChatGPT and More
-
MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors
-
DOSIsoft PLANET® Onco Dose receives CE MDR Mark and new FDA 510(k) clearance
-
Aryaka Featured in 2025 CRN® Partner Program Guide for Growing Investment and Driving Innovation in the Channel
-
CyberArk To Announce First Quarter 2025 Financial Results on May 13
-
Flexsteel Industries, Inc. to Announce Third Quarter 2025 Results on April 21
-
Gift of Life Biologics and Cellex Cell Professionals GmbH Celebrate Successful Partnership to Deliver High-Quality Starting Materials for Final Drug Product Manufacturing in Cell and Gene Therapy
-
Schultz Family Foundation Invests More Than $3 Million in AI-Driven Career Navigation Tools
-
With WaterScope® PLUS, Metron Opens the Door to Smarter Water Management
-
Forcepoint Completes Acquisition of Getvisibility, Uniting AI-Driven Innovation with Data Security Everywhere
-
SPIRE Academy Hires Veteran Volleyball Coach Andy Cole as Program Director and Head Coach
-
Aspargo Labs Expands Global Leadership Team
-
VCI Global Confirms No Material Impact from U.S. Tariffs, Stays Resilient, and Reaffirms Strong Outlook Amid Global Shifts
-
NICE Actimize Introduces Xceed AI Agents for Faster, Smarter Fraud and FinCrime Prevention
-
Oxbridge / SurancePlus to Attend Apex Invest 2025 in Grand Cayman
-
Apex Fintech Solutions Partners with Google Cloud to Bring Capital Markets Technology into the Modern Era
-
Telesat secures substantial multi-year contract with Viasat for Telesat Lightspeed services
-
CareCloud to Present at the LD Micro Invitational XV
-
Stryker to announce financial results for its first quarter of fiscal year 2025
-
ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
-
New Janover Management Team Raises Approximately $42 Million to Enhance U.S. Public Market Digital Asset Treasury Strategy
-
Crypto Industry Leaders Acquire Majority Ownership of Janover Inc.
-
Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology
-
Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum
-
Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025
-
Verizon to report 1Q earnings April 22, 2025
-
Treace Announces Upcoming Board Chair Transition
-
Algorhythm Holdings to Present at the LD Micro Invitational XV Conference
-
Sphera Unveils SpheraCloud Life Cycle Assessment Database Server and Portfolio Analyzer, Boosting LCA Data Quality and Visualization
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Perpetua Resources Corp. of Class Action Lawsuit and Upcoming Deadlines - PPTA

